These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20852247)

  • 1. Efficacy of a spot-on formulation of pyriprole on dogs infested with Sarcoptes scabiei.
    Fourie JJ; Horak IG; de la Puente Redondo V
    Vet Rec; 2010 Sep; 167(12):442-5. PubMed ID: 20852247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs.
    Fourie LJ; Heine J; Horak IG
    Aust Vet J; 2006; 84(1-2):17-21. PubMed ID: 16498829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs.
    Fourie LJ; Du Rand C; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
    Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
    Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs.
    Fourie LJ; Kok DJ; du Plessis A; Rugg D
    Vet Parasitol; 2007 Dec; 150(3):275-81. PubMed ID: 17931787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs.
    Terada Y; Murayama N; Ikemura H; Morita T; Nagata M
    Vet Dermatol; 2010 Dec; 21(6):608-12. PubMed ID: 20880016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the activity of selamectin, imidacloprid and fipronil for the treatment of dogs infested experimentally with Ctenocephalides canis and Ctenocephalides felis felis.
    Cadiergues MC; Caubet C; Franc M
    Vet Rec; 2001 Dec; 149(23):704-6. PubMed ID: 11787782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
    Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
    Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.
    Beugnet F; de Vos C; Liebenberg J; Halos L; Larsen D; Fourie J
    Parasite; 2016; 23():26. PubMed ID: 27317462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
    Loft KE; Willesen JL
    Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
    Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
    Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
    Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
    Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot trial evaluating the efficacy of a 10% imidacloprid/2.5% moxidectin spot-on formulation in the treatment of natural nasal capillariosis in dogs.
    Veronesi F; Morganti G; Di Cesare A; Schaper R; Traversa D
    Vet Parasitol; 2014 Feb; 200(1-2):133-8. PubMed ID: 24365240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a combination of imidacloprid 10%/permethrin 50% versus fipronil 10%/(S)-methoprene 12%, against ticks in naturally infected dogs.
    Otranto D; Lia RP; Cantacessi C; Galli G; Paradies P; Mallia E; Capelli G
    Vet Parasitol; 2005 Jun; 130(3-4):293-304. PubMed ID: 15893431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localised sarcoptic mange in dogs: a retrospective study of 10 cases.
    Pin D; Bensignor E; Carlotti DN; Cadiergues MC
    J Small Anim Pract; 2006 Oct; 47(10):611-4. PubMed ID: 17004955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Louw JP; Ball GS; Pinckney RD; McKibben JS
    Vet Dermatol; 2009 Oct; 20(5-6):447-55. PubMed ID: 20178483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.